Related Experiment Video
Updated: May 9, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Distinct phenotypes of children with perianal perforating Crohn's disease
Scott S Short1, Marla C Dubinsky, Shervin Rabizadeh
1Division of Pediatric Surgery, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Insights
Children with Crohn's disease (CD) who develop perianal perforating disease (PF) during therapy face a more severe condition. These patients are more likely to need surgery, such as diverting ileostomy or colectomy, compared to those diagnosed with PF at the outset.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
- Surgical Outcomes in Crohn's Disease
Background:
- Perianal perforating disease (PF) affects approximately 15% of pediatric Crohn's disease (CD) patients.
- The clinical course of pediatric CD with PF presenting at diagnosis versus developing during therapy is not well understood.
Purpose of the Study:
- To compare the disease course and treatment outcomes of pediatric CD patients who present with perianal perforating disease (PF-CD0) at diagnosis versus those who develop PF during therapy (PF-CD1).
Main Methods:
- A prospective, single-institution observational registry of pediatric CD patients was utilized.
- Children diagnosed with perianal perforating CD (abscesses and/or fistulae) were identified.
- Patients were categorized into PF-CD0 (present at diagnosis) and PF-CD1 (developed during therapy) groups for comparison.
Main Results:
- Of 215 children with CD, 38 (18%) developed PF over a median follow-up of 4.5 years.
- PF-CD0 patients (n=26) were more likely to be younger males.
- PF-CD1 patients (n=12) showed a significantly higher likelihood of requiring diverting ileostomy (42% vs. 8%) and colectomy (33% vs. 4%).
- Multivariable analysis indicated that PF-CD1 independently predicted an increased rate of diverting ileostomy (OR 19.1).
Conclusions:
- Pediatric CD patients developing PF during therapy exhibit a more severe disease phenotype.
- These patients have a substantially higher probability of requiring surgical interventions like diverting ileostomy or colectomy compared to those presenting with PF at diagnosis.
Purpose:
Perianal perforating disease (PF) has been reported in approximately 15% of children with Crohn's disease (CD). It is unknown whether children who present with PF at the time of diagnosis have a different course than those that develop PF while on therapy.
Methods:
From a prospective, single institution observational registry of children diagnosed with CD, we identified children with perianal perforating CD, defined as perianal abscesses and/or fistulae. Patients who presented with perianal perforating CD (PF-CD0) were compared to those who developed perianal perforating CD (PF-CD1) after initial diagnosis.
Results:
Thirty-eight of 215 (18%) children with CD had PF-CD during a median follow up of 4.5 years. Patients with PF-CD0 (n=26) tended to be more likely male (81% vs. 50%, p=0.07) and younger (9.3 yrs vs. 12.5 yrs, p=0.02). PF-CD1 (n=12) patients were more likely to require diverting ileostomy (42% vs. 8%, p=0.02) and colectomy (33% vs. 4%, p=0.03). Multivariable analysis predicted increased rate of diverting ileostomy in the PF-CD1 group (p=0.007, OR 19.1, 95% CI 1.6-234.8).
Conclusion:
Pediatric CD patients who develop PF while on therapy for CD have a more severe phenotype and are more likely to require diverting ileostomy or colectomy compared to those who present with PF-CD.
More Related Videos
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease IV: Clinical Manifestations
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...